|
⚲
|
| Keyboard |
| Giles Colin
✚
|
|
|---|---|
| CIK # | 0001632546 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001632546] | |
| 4 | [0001632546] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Giles Colin | |
| Nexvet Biopharma PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
|
2015-09-03 | Grant | 16,162 | $0.00 | |
|
Nexvet Biopharma PLC NVET
Ordinary Shares
|
2015-07-01 | Option exercise | 2,098 | $0.13 | 273 |
|
Nexvet Biopharma PLC NVET
Restricted Share Units · derivative
|
2015-07-01 | Option exercise | 2,098 | $0.00 | |
|
Nexvet Biopharma PLC NVET
Ordinary Shares
|
2015-06-08 | Grant | 3,147 | $0.13 | 409 |
|
Nexvet Biopharma PLC NVET
Option to Purchase Shares · derivative
|
2015-05-18 | Grant | 40,000 | $0.00 | |
|
Nexvet Biopharma PLC NVET
Ordinary Shares
|
2015-02-10 | Conversion | 6,352 | ||
|
Nexvet Biopharma PLC NVET
Series B Preference Shares · derivative
|
2015-02-10 | Conversion | 6,352 |